Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2022 Earnings Call Transcript

Operator: Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode.

Related Keywords

Brazil ,China ,United States ,Chinese ,America ,American ,Steve Wargacki ,Jason Butler ,Andreas Argyrides ,Thomas Flaten ,Gary Nachman ,Ernie Toth ,Dan Barber ,Rd Steve Wargacki ,Ram Selvaraju ,Ken Truitt ,James Malloy ,Francois Brisebois ,Bennett Watson ,Ken Marshall ,Alliance Global Partners ,Biodelivery Sciences International ,Nasdaq ,American Academy Of Allergy ,Aquestive Therapeutics Inc ,Exchange Commission ,Trademark Office ,Assertio Holdings ,Office Of Orphan Products Development ,Otter Pharmaceuticals ,Aquestive Therapeutics ,Call Transcript March ,Aquestive Therapeutics Fourth Quarter ,Full Year ,Chief Executive Officer ,Chief Financial Officer ,Vice President ,Chief Commercial ,Risk Factors ,Epinephrine Sublingual Film ,American Academy ,Scientific Advisory Board ,South America ,Orphan Products Development ,Preview Division ,Buccal Film ,Chief Commercial Officer ,Hypera Brazil ,Epinephrine Prodrug ,Alliance Global ,